Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPVG.L Regulatory News (PVG)

  • There is currently no data for PVG

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.3 - Ark Therapeutics Group

6 Feb 2013 11:18

ABERFORTH PARTNERS LLP - Form 8.3 - Ark Therapeutics Group

ABERFORTH PARTNERS LLP - Form 8.3 - Ark Therapeutics Group

PR Newswire

London, February 6

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A

PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the "Code")

1. KEY INFORMATION

(a) Identity of the person whose positions/ Aberforth Partners LLP, on

dealings are being disclosed: behalf of discretionary clients. (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient (c) Name of offeror/offeree in relation to Ark Therapeutics Group plc whose relevant securities this form relates: Use a separate form for each offeror/offeree (d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: (e) Date position held/dealing undertaken: 05 February 2013 (f) Has the discloser previously disclosed, or Y/N NO are they today disclosing, under the Code in respect of any other party to this offer? If YES, specify which:

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

(a) Interests and short positions in the relevant securities of the offeror orofferee to which the disclosure relates following the dealing (if any)

Class of relevant security: Ordinary Shares Interests Short positions Number % Number % (1) Relevant securities owned 28,860,092 13.79 0 0.0 and/or controlled: (2) Derivatives (other than options): (3) Options and agreements to purchase/sell: TOTAL: 28,860,092 13.79 0 0.0

All interests and all short positions should be disclosed.

Details of any open derivative or option positions, or agreements to purchaseor sell relevant securities, should be given on a Supplemental Form 8 (OpenPositions).

(b) Rights to subscribe for new securities (including directors' and otherexecutive options)

Class of relevant security in N/A relation to which subscription right exists: Details, including nature of the N/A rights concerned and relevant percentages:

If there are positions or rights to subscribe to disclose in more than oneclass of relevant securities of the offeror or offeree named in 1(c), copytable 2(a) or (b) (as appropriate) for each additional class of relevantsecurity.

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

(a) Purchases and sales

Class of relevant Purchase/sale Number of Price per unit security securities Ordinary Shares Sale 2,915,000 1.009p

(b) Derivatives transactions (other than options)

Class of Product Nature of dealing Number of Price per relevant description reference unit security e.g. opening/closing a securities e.g. CFD long/short position, increasing/reducing a long/short position N/A

(c) Options transactions in respect of existing securities

(i) Writing, selling, purchasing or varying

Class of Product Writing, Number of Exercise Type Expiry Option relevant description purchasing, securities price

date money security e.g. call selling, to which per unit e.g.

paid/

option varying option American, received etc. relates European per unit etc. N/A (ii) Exercising Class of relevant Product Number of Exercise price per security description securities unit e.g. call option N/A

(d) Other dealings (including subscribing for new securities)

Class of relevant Nature of dealing Details Price per unit security (if applicable) e.g. subscription, conversion N/A

The currency of all prices and other monetary amounts should be stated.

Where there have been dealings in more than one class of relevant securities ofthe offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (asappropriate) for each additional class of relevant security dealt in.

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or

understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person

making the disclosure and any party to the offer or any person acting in concert with a party to the offer: If there are no such agreements, arrangements or understandings, state "none" None

(b) Agreements, arrangements or understandings relating to options orderivatives

Details of any agreement, arrangement or understanding, formal or informal,

between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or (ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced: If there are no such agreements, arrangements or understandings, state "none" None (c) Attachments

Is a Supplemental Form 8 (Open Positions) attached? NO

Date of disclosure: 06 February 2013 Contact name: David Holland, for Aberforth Partners LLP Telephone number: 0131 220 0733

Public disclosures under Rule 8 of the Code must be made to a RegulatoryInformation Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk . The Panel's Market Surveillance Unit isavailable for consultation in relation to the Code's dealing disclosurerequirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk .
Date   Source Headline
16th Sep 20167:00 amRNSUS EXPANSION UPDATE AND ISSUE OF LOAN NOTES
7th Sep 20164:35 pmRNSPrice Monitoring Extension
5th Sep 20164:53 pmRNSContract Extension
1st Sep 20168:33 amRNSConfirmation of Capital Reduction Exercise
24th Aug 20165:16 pmRNSCapital Reduction
24th Aug 20163:14 pmRNSHolding(s) in Company
22nd Aug 201612:49 pmRNSDirector's Dealings
17th Aug 201610:56 amRNSDirector's Dealings
17th Aug 201610:56 amRNSHolding(s) in Company
1st Aug 201610:36 amRNSCooperation Agreement Signed With Zoetis
20th Jul 20167:00 amRNSAppointment of Chief Financial Officer
1st Jul 20167:00 amRNSAppointment of Broker
28th Jun 20167:00 amRNSFurther Major Agreement Signed in the US
27th Jun 20162:35 pmRNSHolding(s) in Company
24th Jun 201610:46 amRNSHolding(s) in Company
21st Jun 20164:10 pmRNSDirector's Dealings
21st Jun 201610:47 amRNSBlock Listing Application and Directors' Dealings
14th Jun 20163:44 pmRNSHolding(s) in Company
14th Jun 20163:39 pmRNSDirector's Dealings
10th Jun 20169:17 amRNSHolding(s) in Company
9th Jun 20167:00 amRNSPREMIER PET CARE PLAN LAUNCHED IN FRANCE
8th Jun 201610:57 amRNSDirector's Dealings
8th Jun 201610:48 amRNSHolding(s) in Company
8th Jun 201610:41 amRNSDirector's Dealings
7th Jun 201610:30 amRNSDirector's Dealings
3rd Jun 201612:41 pmRNSDirector's Dealings
2nd Jun 20167:00 amRNSMajor Agreement Signed in the US
9th May 20164:40 pmRNSSecond Price Monitoring Extn
9th May 20164:35 pmRNSPrice Monitoring Extension
9th May 201610:00 amRNSHolding(s) in Company
9th May 20167:00 amRNSHalf-year Report
5th May 20167:00 amRNSCONTROLLED EXPANSION INTO THE US
26th Apr 20167:48 amRNSRevised Strategy For Pet Care Plan Nordic Region
26th Apr 20167:00 amRNSBoard Changes
6th Apr 20164:40 pmRNSSecond Price Monitoring Extn
6th Apr 20164:35 pmRNSPrice Monitoring Extension
24th Mar 20169:00 amRNSDirector's Dealings
23rd Mar 201611:58 amRNSResult of AGM
23rd Mar 201611:38 amRNSAGM Statement
21st Mar 201610:17 amRNSDirector's Dealings
9th Mar 201611:36 amRNSBlock Listing Application - Withdrawal
8th Mar 20169:00 amRNSBlock Listing Application
2nd Mar 20164:09 pmRNSDirector's Dealings
29th Jan 20167:00 amRNSFinal Results
21st Dec 20157:00 amRNSDISPOSAL OF VETERINARY BUSINESS
20th Oct 20153:55 pmRNSHolding(s) in Company
17th Jul 201510:00 amRNSChange of website address
26th Jun 20153:28 pmRNSResult of AGM
17th Jun 201512:39 pmRNSDirector's Dealings
2nd Jun 20155:10 pmRNSBlocklisting Six Monthly Return

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.